In the present study, Heterometrus fastigiousus venom (HFV) was employed as antigen to produce species-specific scorpion antivenom (SAV) in albino mice (NIH) strain. To determine SAV efficacy, it was pre-incubated with 10 LD 50 of HFV and then injected subcutaneously into mice. Subsequently, mortality was observed after 24 hours. Minimum effective dose (MED) was 12.5 LD 50 of HFV/mL of SAV. SAV effectiveness to reverse HFV-induced biochemical alterations in mice was analyzed by challenge method. Simultaneously, mice received subcutaneously 40% of 24-hour-LD 50 of HFV and intravenously SAV. After four hours, changes in serum glucose, free amino acids, uric acids, pyruvic acid, cholesterol, total protein, alkaline phosphatase, acid phosphatase, lactic dehydrogenase and glutamate-pyruvate transaminase enzyme level were determined. Treatment with species-specific SAV resulted in the reversal of HFV-induced biochemical alterations.
INTRODUCTION
Scorpion stings cause several clinical manifestations in the victim and are common in tropical and subtropical countries (1) . There are several drugs that are employed in the treatment of scorpion envenomations; however, the relief of venom induced hypertension, these substances may cause side effects. Therefore, scientists have turned their attention towards serotherapy as a safer treatment for scorpion stings.
Nevertheless, there are contradictory opinions about the effectiveness of the scorpion antivenoms either in experimental animals or in scorpion sting victims.
Some researchers consider antivenom the only specific treatment against scorpion stings, while others have questioned its usefulness in eliminating scorpion sting complications (2) (3) (4) (5) . However, for quick neutralization of scorpion venom toxic effects, serotherapy is a well-tested pharmaceutical method safely used in patients around the globe (6) (7) (8) .
In India, the efficacy of species-specific antivenoms in neutralizing lethal factors of red scorpion venom has been tested by different scientific groups (9, 10) . Despite the several attempts to investigate the consequences of scorpionism and to produce species-specific antivenom against scorpion venom, Asian black scorpions have attracted little attention. Still, several clinical manifestations of black scorpion stings have been reported (11) (12) (13) (14) . Chaubey (11) reported reduction in erythrocyte and increase in total leucocyte counts, blood hemoglobin, mean corpuscular hemoglobin, packed cell volume and plasma hemoglobin in mice envenomated by Heterometrus fastigiousus venom (HFV). Chaubey and Upadhyay (12) observed that HFV increases levels of glucose, free amino acids, uric acid, pyruvic acid and total protein while decreases cholesterol level in sera of experimentally envenomated albino mice. The same treatment also augmented enzyme activity levels of alkaline phosphatase, acid phosphatase, lactic dehydrogenase and glutamate-pyruvate transaminase in albino mice sera. The present study was carried out to determine the efficacy of species-specific SAV produced against HFV -induced abnormalities in albino mice.
MATERIALS AND METHODS

Venom
Living black scorpions H. fastigiousus were purchased from the animal supplying agency Zoological Animal UP, India. Venom was obtained by electric stimulation of scorpion telson. Both toxicity and LD 50 of HFV has already been determined in albino mice by Chaubey and Upadhyay (12) .
Production of SAV
Species-specific SAV against HFV was produced in albino mice (NIH strain, 25±5 g) using Freund's complete and incomplete adjuvants (respectively, FCA and FICA).
Immunogen for primary immunization was prepared by emulsifying equal volumes of venom and FCA, while boosting immunogen was prepared by emulsifying equal volumes of venom and FICA. Primary immunization was performed by injecting intramuscularly 100 µL of immunogen containing 100 µg HFV. The interval between the first two doses was two weeks and then boosting was done regularly in oneweek intervals with gradually increasing HFV doses. During this period animals were bled randomly to check detectable amount of antibodies by Ouchterlony method (15) . After four months, mice were killed and collected plasma was processed using ammonium sulphate precipitation and pepsin treatment according to Kankonkar et al.
(9)
Neutralizing Ability of Species-specific SAV
The neutralizing ability of the species-specific SAV was tested in albino mice (25 ± 5 g) that were injected subcutaneously with 10 LD 50 of HFV (in 100 μL solution) preincubated with 100 μL, 200 μL, 400 μL, 800 μL and 1000 μL of SAV for two hours at 37°C. Each pre-incubated mixture was subsequently adjusted with physiological buffer saline (PBS) to a final volume of 2 mL. The injection volume was kept constant to 400 μL/mouse. Control group received PBS only. Animal mortality was registered 24 hours after treatment.
Efficacy Determination of Species-specific SAV in the Reversal of HFV-induced
Biochemical Abnormalities
Experimental albino mice were divided into the following three groups:
• Group A: received physiological buffer only (Control group);
• Group B: received 40% of 24-hour-LD 50 of HFV (150 μg);
• 
Statistical Analysis
Results were expressed as mean ± SE of six replicates and were analyzed using Student's t-test to detect significant changes with controls and between treated groups (25) .
RESULTS
To determine antivenom efficacy, mice were injected subcutaneously with 10 LD 50 of HFV pre-incubated with species-specific SAV (100 μL, 200 μL, 400 μL, 800 μL and 1000 μL). After 24 hours, animal survival was recorded and found to rise with increased amount of SAV (Table 1) . Species-specific SAV neutralizes 12.5 LD 50 of HFV/mL.
In another experiment, the efficacy of species-specific SAV to revert augmented levels of serum glucose, free amino acids, pyruvic acid, uric acid as well as to diminish cholesterol and to improve levels of alkaline phosphatase, acid phosphatase, lactic dehydrogenase and glutamate-pyruvate transaminase enzyme activity was determined by challenge method.
SAV significantly reversed biochemical changes induced by HFV (Tables 2 and 3) .
Glucose, free amino acid, uric acid, pyruvic acid and total protein levels in group B mice were 140.48%, 138.39%, 127.27%, 144% and 122.09% of the control group;
and decreased to 106.04%, 104.89%, 107.27%, 108% and 104.53% in animals of group C after treatment with SAV (Table 2) . Cholesterol level in group B was 71.48%
of the control group; and increased to 96.41% in group C mice ( 
DISCUSSION
Lethality due to scorpion stings is a common health problem in developing countries.
Of the 1,500 scorpion species distributed throughout the world, 50 have proven lethal to humans and most of them belong to Buthidae family (26) . However, some species within the family Scorpionidae have also been reported as poisonous including H. fastigiousus (11) (12) (13) (14) . Still, no species-specific antivenom has been produced to treat black scorpion envenomations up to now. Despite contradictory opinions regarding scorpion antivenom effectiveness against scorpionism, research on scorpion antivenom production is advancing.
In the present study, species-specific SAV against HFV was produced and its Therefore, it is quite necessary to develop species-specific scorpion antivenoms.
ACKNOWLEGMENTS
Author is highly thankful to the Head of the Department of Zoology, Deen Dayal Upadhyay Gorakhpur University, for providing laboratory facilities.
